61 results on '"Matthews, Nik"'
Search Results
2. Data from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
3. Supplementary Table S3 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
4. Supplementary Methods, Tables S1 - S2, S4, Figures S1 - S11 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
5. Supplementary Table S3 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
6. Supplementary Methods, Tables S1 - S2, S4, Figures S1 - S11 from Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
7. Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix Cancer
8. CDK4/6 inhibition and dsRNA sensor agonism co-operate to enhance anti-cancer effects through ER stress and immune modulation of tumour cells
9. Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
10. Abstract 1960: Mechanisms of therapeutic synergy between pattern recognition response agonists and cdk4 inhibitors
11. Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
12. The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing
13. Abstract PR06: Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer
14. Mutational processes impact the evolution of anti-EGFR antibody resistance in colorectal cancer
15. Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
16. Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer
17. Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
18. Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
19. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
20. Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
21. Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
22. Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
23. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
24. CEA expression patterns determine response and resistance to the CEA-TCB bispecific immunotherapy antibody in colorectal cancer patient derived organoids.
25. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing
26. Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
27. Abstract LB-094: Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
28. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
29. Erratum: Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
30. Ultra-sensitive mutation detection and genome-wide DNA copy number reconstruction by error corrected circulating tumour DNA sequencing
31. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
32. Tracking the Evolution of Non–Small-Cell Lung Cancer
33. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
34. ERK-Induced Activation of TCF Family of SRF Cofactors Initiates a Chromatin Modification Cascade Associated with Transcription
35. Distinct modes of SMAD2 chromatin binding and remodeling shape the transcriptional response to NODAL/Activin signaling
36. iMYC: Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified oesophagogastric carcinoma.
37. Author response: Distinct modes of SMAD2 chromatin binding and remodeling shape the transcriptional response to NODAL/Activin signaling
38. SRF Co-factors Control the Balance between Cell Proliferation and Contractility
39. The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity
40. Mutation of cancer driver MLL2 results in transcription stress and genome instability
41. Correction: Retention of the Native Epigenome in Purified Mammalian Chromatin
42. Retention of the Native Epigenome in Purified Mammalian Chromatin
43. Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
44. Retraction Note: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
45. A simple biophysical model emulates budding yeast chromosome condensation
46. Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
47. Author response: A simple biophysical model emulates budding yeast chromosome condensation
48. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
49. Abstract 983: Intratumor heterogeneity in non-small cell lung cancer inferred by multi-region exome sequencing
50. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.